<DOC>
	<DOCNO>NCT01216241</DOCNO>
	<brief_summary>The purpose study evaluate benefit side effect daptomycin compare placebo treatment neutropenic fever .</brief_summary>
	<brief_title>Daptomycin Versus Placebo Patients With Neutropenia Fever</brief_title>
	<detailed_description>To determine whether percentage neutropenic subject become afebrile five day fever first develop high daptomycin compare placebo add time anti gram-negative therapy . The five day time point select point recommend add antifungal therapy treatment regimen patient still febrile .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>1 . Patients category currently undergo chemotherapy . 2 . Patients least 18 age . 3 . Patient expect reach absolute granulocyte count &lt; 100 cells/mm3 4 . Patients give write consent criterion must least one temperature great equal 38.3Â° temperature &gt; 38o least two occasion study drug administer . 1 . Patients lymphoma solid tumor undergo initial chemotherapy . Their neutropenia insufficient duration adequate test value antigram positive antibiotic . 2 . Patients undergoing autotransplantation , reason . 3 . Patients evidence clinical infection presence pulmonary infiltrate xray clinical evidence presence cellulitis . 4 . Patients receive daptomycin two week prior enrollment . 5 . Patients concomitant use vancomycin . 6 . Patients creatinine clearance &lt; 30 ml/min CPK &gt; 3x normal 7 . Patients significant hepatic dysfunction , define baseline liver function test &gt; 5x normal . 8 . Patients know allergy daptomycin . 9 . Patients previously study . 10 . Women child bear age either lactating pregnant ( evidence positive urine pregnancy test positive serum betaHCG ) . 11 . Patients previously enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>